Health Catalyst Inc
$ 1.64
2.50%
11 Jun - close price
- Market Cap 118,230,000 USD
- Current Price $ 1.64
- High / Low $ 1.70 / 1.53
- Stock P/E N/A
- Book Value 1.87
- EPS -3.73
- Next Earning Report 2026-08-06
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA -0.03 %
- ROE -1.03 %
- 52 Week High 4.12
- 52 Week Low 0.96
About
Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations. The company is headquartered in South Jordan, Utah.
Analyst Target Price
$1.75
Quarterly Earnings
| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-05-11 | 2026-03-12 | 2025-11-10 | 2025-08-07 | 2025-05-07 | 2025-02-26 | 2024-11-06 | 2024-08-07 | 2024-05-09 | 2024-02-22 | 2023-11-02 | 2023-08-08 |
| Reported EPS | 0.02 | 0.08 | 0.06 | 0.04 | 0.01 | 0.04 | 0.07 | 0.12 | 0.05 | 0.02 | 0.03 | 0.05 |
| Estimated EPS | 0.01 | 0.0954 | 0.07 | 0.04 | 0.03 | 0.0764 | 0.09 | 0.08 | 0.03 | -0.01 | -0.01 | -0.01 |
| Surprise | 0.01 | -0.0154 | -0.01 | 0 | -0.02 | -0.0364 | -0.02 | 0.04 | 0.02 | 0.03 | 0.04 | 0.06 |
| Surprise Percentage | 100% | -16.1426% | -14.2857% | 0% | -66.6667% | -47.644% | -22.2222% | 50% | 66.6667% | 300% | 400% | 600% |
Next Quarterly Earnings
| Jun 2026 | |
|---|---|
| Reported Date | 2026-08-06 |
| Fiscal Date Ending | 2026-06-30 |
| Estimated EPS | 0.03 |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: HCAT
2026-06-11 04:39:01
Health Catalyst, Inc. (HCAT) has filed a Form 144 indicating a proposed sale of 34,485 restricted shares of Common Stock, sourced from compensation, with an intended sale date of June 10, 2026. The filing also notes prior restricted stock sales by the same holder on March 10, May 1, and June 1, 2026. This SEC filing serves as a transparency measure for the market regarding insider trading.
2026-06-10 21:31:47
Health Catalyst (HCAT) stock has garnered investor attention following its presentation at the Goldman Sachs Global Healthcare Conference and its Q1 2026 earnings report, which indicated continued revenue growth and a narrowing net loss. The company, which specializes in healthcare data analytics, saw noticeable intraday stock swings as investors processed updated guidance. Its business model focuses on providing cloud-based data platforms and analytics applications to healthcare organizations, aiming to improve clinical, financial, and operational performance.
2026-06-09 20:09:26
Health Catalyst, Tenable, and Pegasystems stocks experienced a downturn following the release of new AI models by Anthropic, Claude Fable 5 and Claude Mythos 5, which are designed for complex knowledge work and coding problems. This development reinforced the "SaaSpocalypse" thesis, suggesting that more capable AI agents could reduce the need for expensive enterprise software subscriptions. The market weakness was further exacerbated by geopolitical concerns, including an American Apache helicopter incident near Oman and comments from Donald Trump regarding a potential Iranian attack, contributing to a macro headwind for long-duration software assets due to possible sustained higher interest rates.
2026-06-09 03:39:50
Whetstone Capital Advisors and David Atterbury have filed an updated Schedule 13D/A, disclosing a 4.5% beneficial ownership stake in Health Catalyst (HCAT). This stake amounts to 3,285,690 shares, including common stock and shares underlying long call options, and was acquired using approximately $7.83 million in working capital from the funds they advise. The filing indicates shared voting and dispositive power over these shares, with long and short options expiring in December 2026.
2026-06-08 16:40:01
Med-Metrix, a revenue cycle management platform backed by Harvest Partners and A&M Capital Partners, has acquired Vitalware from Health Catalyst for $147 million in cash. Vitalware provides cloud-based revenue integrity and chargemaster management software for hospitals and health systems. This acquisition enhances Med-Metrix's services by adding mid-revenue cycle software capabilities, aligning with its strategy of combining operator-led services with scalable software.
2026-06-08 11:39:51
Health Catalyst has signed a definitive agreement to sell its Vitalware LLC unit to Med-Metrix for $147 million in cash. This strategic divestiture allows Health Catalyst to exit a non-core financial software segment and focus on its primary clinical, operational, and consumer performance improvement technologies. The proceeds will be used to repay its $160 million senior secured term loan facility, improving its balance sheet and redirecting focus to its core data platform and AI roadmap.
